Breaking News

Alvotech Acquires Baliopharm

Baliopharm to be rebranded as Alvotech Germany

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Reykjavík, Iceland-based Alvotech has formed an agreement to acquire Baliopharm GmbH, a German biopharmaceutical development company, previously a subsidiary of Baliopharm AG. The acquisition provides Alvotech with complimentary capabilities in the area of biosimilar development. Baliopharm will be fully integrated into the Alvotech organization and will be rebranded as Alvotech Germany in the near future. “The acquisition of Baliopharm significantly strengthens our R&D platform and will ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters